Ranolazine ( CVT 303 | RS 43285-003 )

产品货号. M19284 CAS No. 95635-55-5

雷诺嗪是一种通过钠/钙通道的钙摄取抑制剂，用于治疗慢性心绞痛。

纯度: >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

规格	价格/人民币	库存	数量
50MG	￥462	有现货
100MG	￥656	有现货
200MG	￥1013	有现货
500MG	￥1717	有现货
1G	获取报价	有现货

产品询价大包装询价加入购物车

生物学信息

产品名称

Ranolazine
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

雷诺嗪是一种通过钠/钙通道的钙摄取抑制剂，用于治疗慢性心绞痛。
产品描述

Ranolazine is a calcium uptake inhibitor via the sodium/calcium channel, used to treat chronic angina. It affects the sodium-dependent calcium channels during myocardial ischemia in rabbits by altering the intracellular sodium level.(In Vivo):Ranolazine (Bolus injection 10 mg/kg and infusion 9.6 mg/kg/h; bolus injection; for 145 minutes; male Wistar rats) treatment significantly reduces infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion.
体外实验

——
体内实验

Ranolazine (Bolus injection 10 mg/kg and infusion 9.6 mg/kg/h; bolus injection; for 145 minutes; male Wistar rats) treatment significantly reduces infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion. Animal Model:Male Wistar rats (240-350 g) Dosage:Bolus injection 10 mg/kg and infusion (9.6 mg/kg/h) Administration:Bolus injection; for 145 minutes Result: Significantly reduced infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion.
同义词

CVT 303 | RS 43285-003
通路

Others
靶点

Other Targets
受体

Calcium Channel
研究领域

Cardiovascular Disease
适应症

——